Post-application efficacy intervals | Group A | Group B | Group C | Group D | p value |
---|---|---|---|---|---|
Immediate | < 0.001¥ | ||||
 (Mean scores ± SD) | 2.03 ± 0.70 | 1.34 ± 0.68 | 1.57 ± 0.81 | 2.17 ± 0.61 | |
 (p value)β | < 0.001 | < 0.001 | < 0.001 | 0.001 | |
 Percent change from baseline (%) | 18.1 | 45.7 | 37.6 | 15.2 | |
Day 3 | 0.016Â¥ | ||||
 (Mean scores ± SD) | 1.91 ± 0.73 | 1.81 ± 0.59 | 1.81 ± 0.53 | 2.19 ± 0.60 | |
 (p value)β | < 0.001 | < 0.001 | < 0.001 | 0.003 | |
 Percent change from baseline (%) | 22.9 | 25.5 | 24.4 | 10.2 | |
Week 2 | < 0.001¥ | ||||
 (Mean scores ± SD) | 1.25 ± 0.71 | 1.30 ± 0.58 | 1.56 ± 0.70 | 2.12 ± 0.68 | |
(p value)β | < 0.001 | < 0.001 | < 0.001 | 0.001 | |
 Percent change from baseline (%) | 48.9 | 46.9 | 37.2 | 14.2 | |
Week 4 | < 0.001¥ | ||||
 (Mean scores ± SD) | 1.03 ± 0.70 | 1.09 ± 0.62 | 1.33 ± 0.64 | 1.91 ± 0.71 | |
 (p value)β | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
 Percent change from baseline (%) | 58.5 | 55.8 | 45.4 | 22.5 | |
Week 6 | < 0.001¥ | ||||
 (Mean scores ± SD) | 0.97 ± 0.68 | 0.97 ± 0.68 | 1.18 ± 0.57 | 1.82 ± 0.67 | |
 (p value)β | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
 Percent change from baseline (%) | 61.1 | 60.1 | 53.4 | 25.0 |